ABR |
auditory brainstem responses |
AD |
Alzheimers disease |
AGEs |
advanced glycation end products |
CAPD |
chronic ambulatory peritoneal dialysis |
CFS |
chronic fatigue syndrome |
CL |
cardiolipin |
CoQ10 |
coenzyme Q10 |
CVD |
cardiovascular disease |
DAG |
diacylglycerol |
DAMPs |
damage associated molecular patterns |
DHA |
docosahexaenoic acid |
EPA |
eicosapentaenoic acid |
EPL |
essential phospholipids |
ETC |
electron transport chain |
FA |
fatty acid |
FDA |
US Federal Drug Administration |
GPL |
glycerolphospholipids |
GRAS |
generally recognized as safe |
HDL |
high density lipoproteins; HNE 4-hydroxynonenal |
IL |
interleukin |
MDA |
malondialdehyde |
MetSyn |
metabolic syndrome |
MIM |
mitochondrial inner membrane |
MLR |
membrane lipid replacement |
mPTP |
mitochondrial permeability transition pores |
mtDNA |
mitochondrial DNA |
NCD |
non-communicable diseases |
NF-κB |
nuclear factor kappa B |
PC |
phosphatidylcholine |
PE |
phosphatidylethanolamine |
PG |
phosphatidylglycerol |
PI |
phosphatidylinositol |
PS |
phosphatidylserine |
RNS |
reactive nitrogen species |
ROS |
reactive oxygen species |
TNFα |
tumor necrosis factor alpha |
T2D |
type 2 diabetes |